Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2620864rdf:typepubmed:Citationlld:pubmed
pubmed-article:2620864lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2620864lifeskim:mentionsumls-concept:C0677886lld:lifeskim
pubmed-article:2620864lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:2620864lifeskim:mentionsumls-concept:C1524119lld:lifeskim
pubmed-article:2620864lifeskim:mentionsumls-concept:C0032433lld:lifeskim
pubmed-article:2620864lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:2620864pubmed:issue4lld:pubmed
pubmed-article:2620864pubmed:dateCreated1990-3-28lld:pubmed
pubmed-article:2620864pubmed:abstractTextFree and acetylated urinary putrescine, spermine and spermidine levels (UPA) and total polyamine excretion were measured by high-performance liquid chromatography in 57 patients with epithelial ovarian cancer (EOC) and 43 control patients. Mean UPA levels were higher and the number of abnormal UPAs per sample greater for cancer patients but maximum single UPA sensitivity was only 29%. No control subject had more than 2 abnormal UPA values compared with 42% of patients with EOC. Rising UPA levels reflected progressive disease in 83% of patients and fell with tumour response in 66%.lld:pubmed
pubmed-article:2620864pubmed:languageenglld:pubmed
pubmed-article:2620864pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2620864pubmed:citationSubsetIMlld:pubmed
pubmed-article:2620864pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2620864pubmed:statusMEDLINElld:pubmed
pubmed-article:2620864pubmed:issn0378-7346lld:pubmed
pubmed-article:2620864pubmed:authorpubmed-author:GriffinMMlld:pubmed
pubmed-article:2620864pubmed:authorpubmed-author:SlackJJlld:pubmed
pubmed-article:2620864pubmed:authorpubmed-author:LawtonFFlld:pubmed
pubmed-article:2620864pubmed:authorpubmed-author:BlackledgeGGlld:pubmed
pubmed-article:2620864pubmed:issnTypePrintlld:pubmed
pubmed-article:2620864pubmed:volume28lld:pubmed
pubmed-article:2620864pubmed:ownerNLMlld:pubmed
pubmed-article:2620864pubmed:authorsCompleteYlld:pubmed
pubmed-article:2620864pubmed:pagination212-4lld:pubmed
pubmed-article:2620864pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:meshHeadingpubmed-meshheading:2620864-...lld:pubmed
pubmed-article:2620864pubmed:year1989lld:pubmed
pubmed-article:2620864pubmed:articleTitleUrinary polyamine excretion patterns in patients with epithelial ovarian cancer.lld:pubmed
pubmed-article:2620864pubmed:affiliationDepartment of Obstetrics and Gynaecology, University of Birmingham, UK.lld:pubmed
pubmed-article:2620864pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2620864lld:pubmed